Researchers at the Icahn School of Medicine at Mount Sinai have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant infections.
The findings show that in preclinical studies in mice and human lung tissue…
The findings show that in preclinical studies in mice and human lung tissue…